Peptilogics
A clinical stage company advancing a novel anti-biofilm therapeutic for medical device-related infections.
Last updated September 1, 2026
AI crawler reads
2requests
1companies- Anthropic2
- Profile
- 2
- Controversies
- 0
- JSON · MD
- 0
- First read
- Nov 4, 2026
- Latest read
- Nov 4, 2026
From this site's server log
Overview
Peptilogics is a clinical stage company headquartered in Pittsburgh, Pennsylvania, dedicated to curing and preventing medical device-related infection. Its lead engineered peptide, zaloganan (PLG0206), is a novel anti-biofilm therapeutic for the treatment and prevention of devastating and costly medical device-related infections, specifically designed to address prosthetic joint infections.
History
Peptilogics is a clinical stage company advancing its lead engineered peptide, zaloganan (PLG0206), a novel anti-biofilm therapeutic, for the treatment and prevention of devastating and costly medical device-related infections. The company is headquartered in Pittsburgh, Pennsylvania. Its lead investigational program zaloganan (PLG0206) has been specifically designed to address the serious and life-threatening condition of prosthetic joint infections.
Products and positioning
zaloganan (PLG0206)
A novel anti-biofilm therapeutic for the treatment and prevention of medical device-related infections, specifically designed to address prosthetic joint infections.
Sources4 sources
Cite this profile: Cite the canonical profile. /brand-wiki/peptilogics · Editorial policy · How profiles are compiled